Shariatga muvofiqlik sharhi
Halol emasRapport Therapeutics, Inc. Common Stock (RAPP) hozirda Akinda shariat skriningi (AAOIFI) bo'yicha Halol emas deb tasniflanadi.
Rapport Therapeutics, Inc. Common Stock haqida
Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating its efforts on discovering and developing innovative small-molecule therapeutics for individuals living with central nervous system (CNS) disorders.
Rapport Therapeutics, Inc. Common Stock (RAPP) Healthcare sektorida, Biotechnology sohasida faoliyat yuritadi.
Nega halol deb hisoblanmaydi: aksiya quyidagi tekshiruvlardan o'tmaydi: Kompaniya faoliyati, Foizli qimmatli qog‘ozlar va aktivlar.
- Kompaniya faoliyati
- 100.00%Chegara 5%Muvaffaq emas
- Foizli qarz
- 1.16%Chegara 30%Muvaffaq
- Foizli qimmatli qog‘ozlar va aktivlar
- 65.19%Chegara 30%Muvaffaq emas
- Dividendlarni poklash
- 100.00%Xayriyaga beriladigan dividend ulushiPoklash kalkulyatori
Oxirgi yangilanish: 3-noy, 2026 · Skrining ma'lumot uchun; bu fatvo emas. Shaxsiy maslahat uchun malakali olim bilan maslahatlashing.
Kontentni ko'rish uchun tizimga kiring
Kontentni ko'rish uchun tizimga kiring
Kontentni ko'rish uchun tizimga kiring
Kompaniya profili
Kontentni ko'rish uchun tizimga kiring
Tez-tez beriladigan savollar
Rapport Therapeutics, Inc. Common Stock (RAPP) bo‘yicha qisqa javoblar. Akinda skrining yorlig‘i: Halol emas.
